Patients with Merkel cell carcinoma who underwent a procedure called sentinel lymph node biopsy had a lower risk of cancer recurrence after two years, according to a new study. When the biopsy’s results were used to guide subsequent tests and treatment, these patients had longer survival rates than patients who had not undergone the procedure.